santé globale

Blog written by Jean-Hervé Bradol, director of studies at the Crash.

Today, in order to obtain supplies of vaccines against Covid-19, there is neither a major difficulty related to price, nor a major obstacle related to intellectual property rules, nor a deficit in bio-medical research. However, these three topics are generally at the heart of MSF's communication in the area of access to medical care for those in most need. Our discourse must therefore evolve.
With the emergence of worrying variants of the virus present in the early stages of the pandemic and, as a consequence, the need to vaccinate on a global scale as quickly as possible, the world is facing a double challenge: biological engineering and ultra-industrial production – “ultra” echoing the need to produce on a global scale in a short period of time.

Following an article co-written by members of the Swiss and Canadian sections of MSF, Fabrice Weissman presents a critical analysis of the arguments put forward by his colleagues. An analysis that could be useful to the entire movement, and to the humanitarian community as a whole.

The study The Patient Perspective of Quality of Care: A Review of the Literature, which we present here was carried out by Hannah Barnett a public health student at George Washington University, intern with CRASH from June to August 2018. This work sums up seventy articles from a variety of disciplines including medicine and public health. It is part of a reflection initiated by MSF a few years ago on medical quality and the patient-centered approach.

The CRASH team invited you to the debate-conference “Healing foreigners in France: The State and the civil society organisations from the 80s to the 90s” on Monday 17th of December 2018 from 6 to 8pm, in the 1rst floor room at the 8 rue Saint-Sabin. We hosted Caroline Izambert, who recently defended, at the EHESS, her PhD thesis focusing on the foreigners’ access to healthcare in France. Her title: “Heal foreigners?” The State and the civil society organisations for the health coverage of the poor and foreigners in France from the 1980s to the present day.